Saturday 17 October 2026 Export BIO’s income statement to Excel — free account

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 19.0%, free cash flow fell 6.06% and total debt was flat, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

353.70 11.12 −3.05%

Follow BIO

Alert me

Market cap: $9.8B
P/E: 42.5×
Fwd P/E: 35.4×
Dividend yield: —
F-score: 5/9
Altman Z: 3.20
Beneish M: −2.29
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	10.84	45.62	35.25
P/S ratio Full definition →		2.95	3.20	2.90	3.03
P/FCF ratio Full definition →		22.27	21.93	20.91	22.11
P/Operating CF Full definition →		62.44	50.09	69.51	79.56
P/B ratio Full definition →		1.12	1.11	1.10	1.09
Price to Tangible BV Full definition →		1.31	1.23	1.23	1.22
EV/Sales Full definition →		2.87	3.07	2.76	2.87
EV/EBITDA Full definition →		32.66	167.85	124.19	140.08
EV/Operating CF Full definition →		14.92	14.89	14.02	15.10
EV/FCF Full definition →		21.64	21.03	19.90	20.95
Quick Ratio Full definition →		3.61	3.87	2.17	2.14
Current Ratio Full definition →		5.44	5.62	3.21	3.14
Net Debt/EBITDA Full definition →		(3.31)	2.84	(10.60)	(5.71)
Debt/Assets Full definition →		12.40%	11.37%	12.29%	11.74%
Debt/Equity Full definition →		0.18	0.16	0.18	0.17
Asset Turnover Full definition →		0.25	0.26	0.27	0.25
Operating CF/Net income Full definition →		(0.35)	0.23	(0.21)	0.27
Capex/Depreciation Full definition →		0.00	(0.28)	0.00	0.00
Interest Coverage Full definition →		5.31	(9.83)	2.77	6.00
Research and Development Expense of Revenue Full definition →		10.92%	0.00%	0.00%	9.40%
Selling, General and Administrative Expense of Revenue Full definition →		31.67%	31.88%	35.87%	32.57%
Intangible Assets out of Total Assets Full definition →		0.10	0.07	0.08	0.07
Share Based Compensation of Revenue Full definition →		0.00%	8.37%	0.00%	0.00%
Graham Net Nets Full definition →		(0.02)	(0.03)	0.00	(0.01)
Graham Number Full definition →		0.00	414.65	186.92	224.21
Earnings Yield Full definition →		(8.67%)	9.22%	2.19%	2.84%
Free Cash Flow Yield Full definition →		4.49%	4.56%	4.78%	4.52%
Revenue per Share Full definition →		24.25	25.43	21.96	24.34
Operating CF per Share Full definition →		4.49	6.05	4.01	3.69
Capex per Share Full definition →		(1.18)	(1.68)	(1.11)	(1.20)
Free Cash Flow per Share Full definition →		3.31	4.37	2.90	2.49
Cash per Share Full definition →		52.69	56.51	58.04	60.51
Shareholders Equity per Share Full definition →		250.22	273.40	254.15	268.22
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		250.22	273.40	254.15	268.22
Free Cash Flow Full definition →		89.20	119.10	78.20	66.60
Working Capital Full definition →		2,319.70	2,389.20	2,025.10	2,059.20
Capital Expenditures Full definition →		(31.70)	(45.80)	(29.90)	(32.10)
Net Current Asset Value Full definition →		(117.60)	(216.70)	3.40	(57.60)
EV/EBIT Full definition →		32.66	167.85	124.19	140.08
Capex to Sales Full definition →		0.05	0.07	0.05	0.05
Price to Operating Income Full definition →		33.63	175.01	130.46	147.89
Other line items
Average Receivables Full definition →		463.32	456.55	425.45	455.85
Average Payables Full definition →		125.49	125.65	135.50	141.40
Average Inventory Full definition →		793.74	750.35	780.30	789.70
Average Assets Full definition →		10,149.94	9,970.30	9,658.45	10,233.05
Average Common Equity Full definition →		7,112.33	7,011.45	6,765.35	7,151.30

Fold the line items

Columns are period end dates

Stockrow Weekly